Laboratory Management
Collapse AMP 2016 Annual Meeting Highlights - Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory
Recordings of Selected Presentations

Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

This collection will give you access to the recordings of the presentations (listed below) and pdf slides only. CME/CMLE or SAM is not available for this collection


Description:

Did you miss out on joining us in Charlotte for the AMP 2016 Annual Meeting? Were you there but missed something you really wanted to see? We have you covered with the AMP 2016 Annual Meeting Highlights. Select presentations were recorded and are now available for online viewing.

 

Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory

As tests for large numbers of rare genetic conditions come on-line in clinical laboratories, it is becoming increasing difficult to obtain high-quality, well-characterized human samples to use for the purposes of test development, validation, and ongoing proficiency testing. The first presentation will review how the CDC GeT-RM program is helping laboratories access samples for these purposes. Non-invasive prenatal screening (NIPS) for the common triploidies, Down (T21), Edward (T18) and Patau (T13) syndromes, as well as numerical abnormalities of the sex chromosomes, is now firmly established as an extremely valuable screening tool. However, there is currently no universally accepted or adopted proficiency test (PT) for NIPS. The second presentation will review the substantial challenges in developing PT for NIPS, and review progress in its development.

- Identify the sample resources available to laboratories through the Get-RM program.

- Explain the challenges and current progress toward developing PT samples for NIPS testing.

 

Development of Reference Materials for Proficiency Testing and Quality Assurance

Lisa V. Kalman, PhD, Centers for Disease Control and Prevention, Atlanta, GA, USA

External Proficiency Assessment of Prenatal Cell Free (cf )DNA Testing for Aneuploidy

Glenn E. Palomaki, PhD, Women & Infants Hospital, Providence, RI, USA

Duration1.5 hr

Recording Date: November 10, 2016


You might also be interested in:

NoteJoin the AMP Family to purchase many of the content for a deep discount!

Formats Available: AMP 2016 Highlights - Kalman & Palomaki
Original Course Date: November 10, 2016
On-Demand Release Date: Available Now
MORE INFOMORE INFO AMP 2016 Annual Meeting Highlights - Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory
Collapse The ABCs of CPT<sup>®</sup> Coding (CE Available)
A Webinar Presented by the AMP Economic Affairs Committee

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

Knowledge of the coding structure of molecular medicine is crucial as these codes are incorporated and used by insurers to identify the services you provide to patients and understanding the basics of CPT® coding will benefit your laboratory practice and management. The American Medical Association (AMA) Current Procedural Terminology (CPT®) coding system is used throughout the United States as a main system of coding for health care services, including laboratory and pathology procedures. The AMP Economic Affairs Committee (EAC) is intimately involved in this process, both by submitting code change applications regularly but also by occupying a rotating seat on the Pathology Coding Caucus, which reviews and provides recommendations to the AMA CPT® Editorial Panel on applications for new or revised pathology and laboratory services. During this webinar, AMP members will be provided with a better understanding of the intricacies of the CPT® coding structure and process for laboratory and pathology codes. This webinar will also educate members by providing resources and tips for submitting your own code change application.


Speakers: Anthony N. Sireci, MD;  Aaron D. Bossler, MD, PhD; and Victoria M. Pratt, PhD

Moderator: Cecilia S. Yeung, MD

Duration: 1 hr

Level of Instruction: Basic


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by Sept 18, 2021

 

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Streaming
Original Course Date: September 18, 2018
MORE INFOMORE INFO The ABCs of CPT<sup>®</sup> Coding (CE Available)
Collapse The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer

Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.


Recent definitions for clinical utility of molecular tests focus on whether a test result will alter treatment. This definition neglects other uses of molecular testing to diagnose disease, manage symptoms, prognosticate or predict future disease. The fullest realization of precision medicine will require embracing all aspects of clinical utility. This three-part webinar series, supported by AMP, presents the discussions of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility (FEND) working group, and its resulting publication, “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology” (Joseph L, et al. J Mol Diagn. 2016;18[5]:605–619).

 

Part 1 - An Overview of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility

Speakers: Loren Joseph, MD; Elaine Lyon, PhD

Host: Roger Klein, MD, JD

 

Part 2 - AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Oncology Cases

Speakers: Pranil Chandra, DO, FCAP, FASP; Rajyasree Emmadi, MD, FCAP

Host: Loren Joseph, MD

 

Part 3: AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Inherited Conditions

Speakers: Stephanie Hallam, PhD, FACMG, MBA; Victoria Pratt, PhD, FACMG

Host: Elaine Lyon, PhD

Practice Guideline Available Here

Total Duration: 3 hr

Level of Instruction: Advanced

 

You might also be interested in:

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

Formats Available: Streaming
Original Course Date: September 28, 2016
MORE INFOMORE INFO The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer